Prospex Energy PLC / Index: AIM / Epic: PXEN / Sector: Oil and Gas
22 December 2021
Prospex Energy PLC
Conversion of Loan Note and TVR
Prospex Energy PLC, ('Prospex' or the 'Company') the AIM quoted investment company (AIM:PXEN) focused on European gas and power projects, announces that it has issued a total of 487,804 ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares"), following the conversion of a convertible loan note granted in December 2020 (the "2020 CLN").
This is the final conversion of the remaining 2020 CLNs, being a conversion of
Admission to Trading
The Company has today applied to the London Stock Exchange for admission of 487,804 new Ordinary Shares to trading on AIM ('Admission'). Admission is expected to occur on or around 30 December 2021. On 22 December 2021 there are 176,822,479 Ordinary Shares in issue and 7,361 shares held in Treasury. Following Admission, there will be 177,310,283 Ordinary Shares in issue. Deducting the 7,361 held in Treasury there will accordingly be 177,302,922 Ordinary Shares that may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
* * ENDS * *
For further information visit www.prospex.energy or contact the following:
Mark Routh |
Prospex Energy PLC |
Tel: +44 (0) 20 7236 1177 |
Rory Murphy |
Strand Hanson Limited
|
Tel: +44 (0) 20 7409 3494 |
Colin Rowbury |
Novum Securities Limited |
Tel: +44 (0) 20 7399 9427 |
Duncan Vasey |
Peterhouse Capital Limited |
Tel: +44 (0) 20 7220 9797 |
Susie Geliher |
St Brides Partners Ltd
|
Tel: +44 (0) 20 7236 1177 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.